Joseph Meyerovitch
Sheba Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joseph Meyerovitch.
Molecular and Cellular Biochemistry | 1995
Yoram Shechter; Jingping Li; Joseph Meyerovitch; Dov Gefel; Rafael Bruck; Gerard Elberg; David S. Miller; Assia Shisheva
Most or all mammalian cells contain vanadium at a concentration of 0.1–1.0 μM. The bulk of the vanadium in cells is probably in the reduced vanadyl (IV) form. Although this element is essential and should be present in the diet in minute quantities, no known physiological role for vanadium has been found thus far. In the years 1975–1980 the vanadate ion was shown to act as an efficient inhibitor of Na+,K+-ATPase and of other related phosphohydrolyzes as well. In 1980 it was observed that vanadate vanadyl, when added to intact rat adipocytes, mimics the biological actions of insulin in stimulating hexose uptake and glucose oxidation. This initiated a long, currently active, field of research among basic scientists and diabetologists. Several of the aspects studied are reviewed here.
Archives of Disease in Childhood | 2012
Joseph Meyerovitch; Felice Antebi; Sari Greenberg-Dotan; Ornit Bar-Tal; Zeev Hochberg
Objectives To determine whether an altered hypothalamic-pituitary-thyroid axis is inherent to Downs syndrome or if a high level of thyroid-stimulating hormone (TSH) is a feature in a subset of patients with Downs syndrome. Design Comparative analysis. Setting Major health maintenance organisation (3.8 million insured). Patients A data warehouse search identified all subjects with Downs syndrome who attended Clalit Health Services in 2006 and were tested for TSH and free thyroxine (T4) level on the day of diagnosis (intention-to-treat population). The study group consisted of patients who were not diagnosed with thyroid disease or did not receive thyroid-modulating medication (n=428). Their findings were compared with a control group of healthy age- and sex-matched subjects who were randomly selected from the general population. Main outcome measures Distribution of free T4, TSH and total T3 levels. Results The distribution plot for TSH showed a significant shift of the curve to higher values in the study group compared with the controls (p≤0.0001). This finding held true on further analysis of the whole intention-to-treat population (p<0.006). The free T4 distribution curve also shifted significantly to higher levels in patients with Downs syndrome (p≤0.0001). Conclusions Downs syndrome is associated with higher TSH levels. The results suggest that hyperthyrotropinaemia is an innate attribute of chromosome 21 trisomy. Therefore, T4 treatment should not be contemplated in Downs Syndrome unless the TSH is >95th centile in the presence of normal-range free T4 levels.
Clinical Pediatrics | 2004
Dalit Modan-Moses; Yoram Bujanover; Saralee Glasser; Joseph Meyerovitch
Obesity is a serious health problem, and is becoming increasingly common in affluent societies. In 1998, an Expert Committee published guidelines regarding obesity evaluation and treatment. The purpose of this study was to assess the attitude of primary care physicians in Israel toward diagnosis and treatment of childhood obesity, as related to the recommended guidelines. Primary physicians caring for children and adolescents were asked to complete an anonymous questionnaire including personal and professional details, methods of diagnosis, documentation and treatment of childhood obesity, and familiarity with and implemention of the Expert Committee recommendations. One hundred forty-four physicians, treating approximately 100,000 children monthly, completed the questionnaire. Ninety-four percent were considered to have diagnosed obesity properly. Furthermore, only 19% reported weighing all children examined, while 99% of the physicians suggested some treatment for obesity. The most frequent recommendations for managing obesity were referral to a dietitian (92%), physical exercise (85%), and group treatment (27%). The majority of physicians (78%) were not familiar with the new Expert Committee recommendations regarding obesity treatment. This study suggests that the majority of primary physicians diagnose obesity properly and recommend accepted modalities to manage obesity. A comprehensive program to prevent and treat obesity is recommended to improve the health status of the population.
Metabolism-clinical and Experimental | 2004
Yuval Heled; Y. Shapiro; Yoav Shani; Daniel S. Moran; Lea Langzam; Varda Barash; Sanford R. Sampson; Joseph Meyerovitch
American Journal of Physiology-endocrinology and Metabolism | 2002
Yuval Heled; Y. Shapiro; Yoav Shani; Dani S. Moran; Lea Langzam; Liora Braiman; Sanford R. Sampson; Joseph Meyerovitch
Biochemistry | 1990
Joseph Meyerovitch; C R Kahn; Yoram Shechter
Israel Medical Association Journal | 2007
Joseph Meyerovitch; Herman Avner-Cohen; Felice Antebi; Michael Sherf
Israel Medical Association Journal | 2008
Itamar Grotto; Salman Zarka; Ran D. Balicer; Michael Sherf; Joseph Meyerovitch
International Journal of Integrated Care | 2016
Maya Leventer-Roberts; Joseph Meyerovitch; Noa Dagan; Galit Shefer; Moshe Hoshen; Nicky Lieberman; Ran D. Balicer
JAMA Internal Medicine | 2008
Bernard Goichot; S. Vinzio; Joseph Meyerovitch; Pnina Rotman-Pikielny; Michael Sherf; Erez Battat; Yair Levy; Martin I. Surks